Patents Examined by Jeffrey Siew
  • Patent number: 6762049
    Abstract: It is often desirable to be able to perform an array of micro-chemical reactions simultaneously but with each reaction proceeding at a different temperature and/or for a different time. A classic example is the polymerase chain reaction associated with DNA analysis. In the present invention, this is achieved by means of an apparatus made up of a chip of plastic, or similar low cost material, containing an array of reaction chambers. After all chambers have been filled with reagents, the chip is pressed up against a substrate, typically a printed circuit board, there being a set of temperature balancing blocks between the chip and the substrate. Individually controlled heaters and sensors located between the blocks and the substrate allow each chamber to follow its own individual thermal protocol while being well thermally isolated from all other chambers and the substrate. The latter rests on a large heat sink to avoid temperature drift over time. A process for manufacturing the apparatus is also disclosed.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: July 13, 2004
    Assignee: Institute of Microelectronics
    Inventors: Quanbo Zou, Uppili Sridhar
  • Patent number: 6756202
    Abstract: A method, apparatus, and computer program product for reading fluorescence signals from an array of chemical moieties (such as different sequence peptides or polynucleotides, for example different DNA sequences). In the method the spatial sequence of scanned locations need not be the same as the temporal sequence. For example, a later illuminated line may be spatially closer to an earlier illuminated line than is a temporally intervening illuminated line.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: June 29, 2004
    Assignee: Agilent Technologies, Inc.
    Inventors: Andreas N. Dorsel, Glenda C. Delenstarr, Kenneth L. Staton, George P. Tsai
  • Patent number: 6753143
    Abstract: The present invention relates to the use asymmetric monolayer forming species and electroconduit forming species to detect target analytes.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: June 22, 2004
    Assignee: Clinical Micro Sensors, Inc.
    Inventors: Chunlin Tao, Changjun Yu
  • Patent number: 6753169
    Abstract: A method of hybridizing a first nucleic acid to a second nucleic acid at least partially complementary to the first nucleic acid by (1) providing a sample vessel and pressure controller for the vessel; and (2) contacting the first and second nucleic acids within the vessel at a pressure above ambient pressure that is effective to enhance hybridization of the first and second nucleic acids.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: June 22, 2004
    Assignee: BBI, BioSeq, Inc.
    Inventors: Robert A. Hess, James A. Laugharn, Jr., David J. Green
  • Patent number: 6753141
    Abstract: Methods for identifying and locating alterations in a nucleic acid having a known sequence are provided. The methods involve measuring the melting temperature of probe nucleic acids hybridized to a target nucleic acid. The methods take advantage of the differential dissociation temperatures of a probe from a target resulting from mismatches at different locations along the region of the target to which the probe hybridizes.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: June 22, 2004
    Assignee: The University of Utah
    Inventors: Philip S. Bernard, Carl T. Wittwer, Gregory Pritham
  • Patent number: 6753148
    Abstract: Methods and apparatus are provided for the analysis and determination of the nature of repeat units in a genetic target. In one method of this invention, the nature of the repeat units in the genetic target is determined by the steps of providing a plurality of hybridization complex assays arrayed on a plurality of test sites, where the hybridization complex assay includes at least a nucleic acid target containing a simple repetitive DNA sequence, a capture probe having a first unique flanking sequence and n repeat units, where n=0,1,2 . . . , or fractions thereof, being complementary to the target sequence, and a reporter probe having a selected sequence complementary to the same target sequence strand wherein the selected sequence of the reporter includes a second unique flanking sequence and m repeat units, where m=0,1,2 . . . , or fractions thereof, but where the sum of repeat units in the capture probe plus reporter probe is greater than 0 (n+m>0).
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: June 22, 2004
    Assignee: Nanogen, Inc.
    Inventors: Ronald G. Sosnowski, Eugene Tu
  • Patent number: 6753147
    Abstract: The identification of pre-defined mutations expected to be present in a minor fraction of a cell population is important for a variety of basic research and clinical applications. The exponential, analog nature of the polymerase chain reaction is transformed into a linear, digital signal suitable for this purpose. Single molecules can be isolated by dilution and individually amplified; each product is then separately analyzed for the presence of pre-defined mutations. The process provides a reliable and quantitative measure of the proportion of variant sequences within a DNA sample.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: June 22, 2004
    Assignee: The Johns Hopkins University
    Inventors: Bert Vogelstein, Kenneth W. Kinzler
  • Patent number: 6737238
    Abstract: To provide a method of making measurements for a sample on the measuring surfaces of a substrate which makes it possible to simplify the control and construction of a measuring device, shorten the measuring period, make the measuring conditions constant, and improve the positional accuracy. The method and a device for carrying out the method are characterized in that measurements for the sample is performed by forming a circular orbit of detection areas, where detection is performed with a detector, on the measuring surfaces of the substrate while moving the detection areas relative to the substrate.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: May 18, 2004
    Assignee: Canon Kabushiki Kaisha
    Inventors: Tomohiro Suzuki, Tadashi Okamoto, Kazuhiro Matsumoto, Nobuko Yamamoto
  • Patent number: 6733977
    Abstract: A body 300 having a cavity 310 for mounting a substrate 120 fabricated with probe sequences at known locations according to the methods disclosed in U.S. Pat. No. 5,143,854 and PCT WO 92/10092 or others, is provided. The cavity includes inlets 350 and 360 for introducing selected fluids into the cavity to contact the probes. Accordingly, a commercially feasible device for use in high throughput assay systems is provided.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: May 11, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Donald M. Besemer, Virginia W. Goss, James L. Winkler
  • Patent number: 6713255
    Abstract: A DNA chip (or PNA chip) composed of a solid carrier and plural DNA fragments (or PNA fragments) fixed onto is the solid carrier at each one end, wherein a plurality of short chain spacer molecules having a hydrophilic moiety at each one end are fixed at each another end onto a surface of the solid carrier having no DNA fragments (or no PNA fragments) on its surface is effective for high sensitive quantitative analysis of a nucleic acid fragment complementary to the DNA fragment (or PNA fragment).
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: March 30, 2004
    Assignee: Fuji Photo Film Co., Ltd.
    Inventors: Yoshihiko Makino, Yoshihiko Abe, Makoto Takagi, Shigeori Takenaka, Kenichi Yamashita, Masashi Ogawa
  • Patent number: 6706481
    Abstract: The present invention provides a method for the in vitro selection of signaling aptamers comprising the steps of synthesizing a DNA pool, the DNA having a random insert of nucleotides of a specific skewed mole ratio; amplifying the DNA pool; transcribing an RNA pool from the amplified DNA using a fluorescently labeled nucleotide; applying the fluorescently labeled RNA pool to an affinity column to remove the high-affinity fluorescent RNA molecules from the fluorescently labeled RNA pool; obtaining a cDNA pool from the high-affinity fluorescent RNA molecules; repeating the amplification and selection steps on the fluorescent RNA molecules and cloning the fluorescent RNA molecules to yield signaling aptamers. Signaling aptamers comprising DNA molecules are also selected for. Also provided is a signaling aptamer that transduces the conformational change upon binding a ligand to a change in fluorescence intensity of the signaling aptamer.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: March 16, 2004
    Assignee: Research Development Foundation
    Inventors: Manjula Rajendran, Andrew D. Ellington, Sulay D. Jhaveri
  • Patent number: 6699655
    Abstract: Methods, systems, kits for carrying out a wide variety of different assays that comprise providing a first reagent mixture which comprises a first reagent having a fluorescent label. A second reagent is introduced into the first reagent mixture to produce a second reagent mixture, where the second reagent reacts with the first reagent to produce a fluorescently labeled product having a substantially different charge than the first reagent. A polyion is introduced into at least one of the first and second reagent mixtures, and the fluorescent polarization in the second reagent mixture relative to the first reagent mixture is determined, this fluorescent polarization being indicative of the rate or extent of the reaction.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: March 2, 2004
    Assignee: Caliper Technologies Corp.
    Inventor: Theo T. Nikiforov
  • Patent number: 6696246
    Abstract: Improved methods for in situ hybridization assays of cellular and subcellular systems and tissue sections, and immobilization-based assay techniques such as Northern blotting, Southern blotting, dot blots, and the like, and assay techniques wherein the probes are bound to substrates are disclosed. The subject invention employs crosslinker-containing hybridization probes capable of forming covalent bonds between the probe and the target nucleic acid. Upon activation, the crosslinker will, if the probe has hybridized with its essentially complementary target, form covalent bonds with the complementary strand to covalently crosslink the probe to the target. Subsequently, stringent wash conditions may be employed to reduce background signals due to non-specific absorption or probes or targets, while retaining all crosslinked probe/target hybrids. Also disclosed are diagnostic kits for use in clinical and diagnostic laboratories.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: February 24, 2004
    Assignee: Naxcor, Inc.
    Inventors: Bingfang Huan, David Albagli, Michael L. Wood, Reuel B. Van Atta, Peter C. Cheng
  • Patent number: 6692918
    Abstract: The present invention provides novel isothermal, single primer linear nucleic acid amplification methods. Methods for amplifying complementary DNA using a composite primer, primer extension, strand displacement, and optionally a termination sequence, are provided. Methods for amplifying sense RNA using a composite primer, primer extension, strand displacement, optionally template switching, a propromoter oligonucleotide and transcription are also provided. The invention further provides compositions and kits for practicing said methods, as well as methods which use the amplification products.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: February 17, 2004
    Assignee: NuGEN Technologies, Inc.
    Inventor: Nurith Kurn
  • Patent number: 6689873
    Abstract: This invention concerns nucleic acid encoding for rat agouti related protein. Agouti related protein is a neuropeptide that may play a role in the central regulation of feeding behavior and energy metabolism via interactions with the melanocortin pathways. This invention also relates to assays utilizing the novel nucleic acid of this invention.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: February 10, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Leonardus H. T. Van der Ploeg, Xiaoming Guan, Hong Yu, Prashant G. Trivedi
  • Patent number: 6689565
    Abstract: Methods, systems, kits for carrying out a wide variety of different assays that comprise providing a first reagent mixture which comprises a first reagent having a fluorescent label. A second reagent is introduced into the first reagent mixture to produce a second reagent mixture, where the second reagent reacts with the first reagent to produce a fluorescently labeled product having a substantially different charge than the first reagent. A polyion is introduced into at least one of the first and second reagent mixtures, and the fluorescent polarization in the second reagent mixture relative to the first reagent mixture is determined, this fluorescent polarization being indicative of the rate or extent of the reaction.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: February 10, 2004
    Assignee: Caliper Technologies Corp.
    Inventor: Theo T. Nikiforov
  • Patent number: 6686152
    Abstract: Methods for the multiplexed detection of known, selected nucleotide target sequences are provided. Detection involves the release of identifying tags as a consequence of target recognition. The methods include the use of electrophoretic tag probes or e-tag probes, comprising a detection region and a mobility-defining region called the mobility modifier, both linked to a target-binding moiety. In practicing the methods, the target-binding moiety of the e-tag probes hybridizes to complementary target sequences followed by nuclease cleavage of the e-tag probes and release of detectable e-tags or e-tag reporters. The mixture is exposed to a capture agent which binds uncleaved and/or partially cleaved e-tag probes, followed by electrophoretic separation. In a multiplexed assay, different released e-tag reporters may be separated and detected providing for target identification.
    Type: Grant
    Filed: April 2, 2001
    Date of Patent: February 3, 2004
    Assignee: Aclara Biosciences, Inc.
    Inventors: Sharat Singh, Huan Tian
  • Patent number: 6686157
    Abstract: Disclosed is a method and compositions for the sensitive detection of the amount and location of specific nucleic acid sequences. The method makes use of a branched oligomer, referred to as a lollipop oligomer, that has a tail portion, a right arm portion, and a left arm portion. These three components are joined at a common junction making a three-tailed structure. The two arms each end with sequences complementary to adjacent sequences in a target sequence. This allows the right and left arms to be ligated together when the oligomer is hybridized to the target sequence, thus topologically linking the oligomer to the target sequence. The tail portion can then be detected at the location of the target sequence.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: February 3, 2004
    Assignee: Molecular Staging Inc.
    Inventors: David C. Ward, Patricia Bray-Ward, Michael J. Lane, Gyanendra Kumar
  • Patent number: 6677120
    Abstract: The present invention is directed to methods for the preparation of 3′-O and 5′-O-levulinyl nucleosides from common precursors using an enzymatic approach.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: January 13, 2004
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Yogesh S. Sanghvi, Vicente Gotor, Miguel Ferrero, Susana Fernandez, Javier Garcia
  • Patent number: RE38442
    Abstract: An improved method allowing for rapid sensitive and standardized detection of a target nucleic acid from a pathogenic microorganism or virus or normal or abnormal gene in a sample is provided. The method involves hybridizing a target nucleic acid to several non-overlapping oligonucleotide probes that hybridize to adjacent regions in the target nucleic acid, the probes being referred to capture/amplification probes and amplifications probes, respectively, in the presence of paramagnetic beads coated with a ligand binding moiety. Through the binding of a ligand attached to one end of the capture/amplification probe and the specific hybridization of portions of the probes to adjacent sequences in the target nucleic acid, a complex comprising the target nucleic acid, the probes and the paramagnetic beads is formed. The probes may then ligated together to form a contiguous ligated amplification sequence bound to the beads, which complex may be denatured to remove the target nucleic acid and unligated probes.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: February 24, 2004
    Assignee: Mount Sinai School of Medicine
    Inventors: David Y. Zhang, Margaret Brandwein